Jason Newland, M.D., M.Ed.  jgnewland@wustl.edu

Profile picture
Professor of Pediatrics, Infectious Diseases
Infectious Diseases

phone: (314) 454-6050

Education

  • BS, University of Notre Dame1996
  • MD, University of Oklahoma College of Medicine2000
  • M Ed, University of Cincinnati, Cincinnati Children's Hospital Medical Center2011

Training

  • Intern and Resident in Pediatrics, University of Nebraska Medical Center and Creighton Medical Center2000 - 2003
  • Fellow, Pediatric Infectious Diseases, Children's Hospital of Philadelphia2003 - 2006
  • Summer Program in Clinical Effectiveness, Harvard School of Public Health2010 - 2010
  • Advanced Improvement Methods, Cincinnati Children's Hospital2013 - 2013
  • Patient Safety Executive Development Program (IHI)2014 - 2014

Licensure and Board Certification

  • 2006 - PresMO, Physician and Surgeon
  • 2006 - PresKS, Physician and Surgeon
  • 2007 - PresABP Subspecialty, Pediatric Infectious Diseases
  • 2015 - PresAmerican Board of Pediatrics

Honors and Awards

  • Eagle Scout1990
  • Novartis Community Service Award, University of Oklahoma College of Medicine1998
  • Podilarian Award for commitment, leadership, and advocacy on the part of patients and fellow students1999
  • William A. Delaney Jr. Award, Outstanding Senior Student in Pediatrics, University of Oklahoma College of Medicine2000
  • IDSA Kass Award for outstanding research by a student or resident2002
  • Pediatric House Officer Teaching Award, University of Nebraska/Creighton University2002
  • George Measaki Award for Outstanding Resident Research, University of Nebraska/Creighton University2003
  • Stephen A. Chartrand Award for Community Service, University of Nebraska/Creighton University2003
  • Teaching Fellow of the Year, Children's Hospital of Philadelphia2004
  • Daniel Scagliotti Award, Educator of the Year, Children's Mercy Hospital-Kansas City2008
  • Kansas City Business Journal Best Doctors List2011
  • Golden Apple Mercy Mentor, Children's Mercy Hospital-Kansas City2012
  • John and Marion Kreamer Research Excellence Award, Excellence in Pediatric Research, Children's Mercy Hospital-Kansas City2013
  • Member, Society of Pediatric Research2013
  • Fellow of Pediatric Infectious Diseases Society2014
  • Kansas City Business Journal Best Doctors List2014
  • Patient Safety Executive Development Scholarship2014
  • Golden Apple Mercy Mentor, Children's Mercy Hospital2014 - 2015
  • Participant, White House Forum on Antibiotic Stewardship2015
  • Member, American Pediatric Society2016
  • Washington University Department of Pediatrics Outstanding Teacher Award-Subspeciality2017
  • CDC/ATSDR Charles C. Shepard Science Award, Assessment, 20172017
  • St. Louis Children's Hospital Residency Program Lecturer of the Month-January 20182018
  • Academic Medical Leadership Program For Physicians and Scientists2019
  • Washington University Department of Pediatrics Outstanding Teacher Award-Subspeciality2019
  • F. Sessions Cole, MD Award in Clinical Excellence 20192019
  • Best Doctor's in America St. Louis - 20192019 - 2020
  • Washington University School of Medicine Department of Pediatrics Outstanding Commitment to Community Physicians Award2020
  • Missouri Association of School Nurses Friends of School Nursing2022
  • St. Louis Children's Hospital Partnership Award 20212022
  • Alpha Omega Alpha Honor Society Inductee2022

Recent Publications view all (175)


  1. An Examination of SARS-CoV-2 Transmission Based on Classroom Distancing in Schools With Other Preventive Measures in Place-Missouri, January-March 2021. Public Health Rep. 2022;137(5):972-979. PMCID:PMC9357822  PMID:35848091 
  2. Correction: Assessing COVID-19 testing strategies in K-12 schools in underserved populations: study protocol for a cluster-randomized trial. BMC Public Health. 2022;22(1):1655. PMCID:PMC9434065  PMID:36050666 
  3. The impact of infectious diseases consultation for children with Staphylococcus aureus bacteremia. Pediatr Res. 2022. PMID:35982140 
  4. Pediatric infectious disease physician perceptions of antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2022;1-4. PMID:35938450 
  5. Quantifying Procedure-level Prophylaxis Misutilization in Pediatric Surgery: Implications for the Prioritization of Antimicrobial Stewardship Efforts. Ann Surg. 2022. PMID:35797034 
  6. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age. N Engl J Med. 2022;386(21):2011-2023. PMID:35544369 
  7. Transmission risk of COVID-19 in high school and college water polo. BMC Infect Dis. 2022;22(1):450. PMCID:PMC9092321  PMID:35546389 
  8. Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures. JAMA Netw Open. 2022;5(5):e2214153. PMID:35616940 
  9. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative. JAMA Pediatr. 2022. PMCID:PMC9062771  PMID:35499841 
  10. Exploring unintended consequences of adult antimicrobial stewardship programs: An Emerging Infections Network survey. Infect Control Hosp Epidemiol. 2022;1-3. PMID:35441586 
  11. A National Survey of Outpatient Parenteral Antibiotic Therapy Practices. J Pediatric Infect Dis Soc. 2022;11(3):115-118. PMID:34939654 
  12. Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia. mBio. 2022;e0019522. PMID:35323040 
  13. Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia. J Infect Dis. 2022. PMID:35249113 
  14. Pediatric Infections in the Time of COVID-19. Infect Dis Clin North Am. 2022;36(1):xiii-xiv. PMCID:PMC8648593  PMID:35168716 
  15. Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial. JAMA Pediatr. 2022;176(3):253-261. PMCID:PMC8767493  PMID:35040920 
  16. Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey. PLoS One. 2022;17(2):e0263767. PMCID:PMC8836310  PMID:35148344 
  17. Acceptance of Saliva-Based Specimen Collection for SARS-CoV-2 Testing Among K-12 Students, Teachers, and Staff. Public Health Rep. 2022;333549221074395. PMID:35137643 
  18. Implementation of School-Based COVID-19 Testing Programs in Underserved Populations. Pediatrics. 2022;149(12 Suppl 2). PMID:34737173 
  19. Building a National Framework to Pair Scientists and Schools During a Global Pandemic. Pediatrics. 2022;149(Suppl 2). PMID:34737179 
  20. Supporting COVID-19 School Safety for Children With Disabilities and Medical Complexity. Pediatrics. 2022;149(12 Suppl 2). PMCID:PMC8926067  PMID:34737172 
  21. Antibiotic spectrum index: A new tool comparing antibiotic use in three NICUs. Infect Control Hosp Epidemiol. 2021;1-5. PMID:34812135 
  22. Outpatient antimicrobial stewardship programs in pediatric institutions in 2020: Status, needs, barriers. Infect Control Hosp Epidemiol. 2021;1-7. PMID:34674785 
  23. Early Antibiotic Exposure in Severe Pediatric Traumatic Brain Injury. J Pediatric Infect Dis Soc. 2021. PMID:34555169 
  24. Indirect Standardization as a Case Mix Adjustment Method to Improve Comparison of Children's Hospitals' Antimicrobial Use. Clin Infect Dis. 2021;73(5):925-932. PMID:33320178 
  25. SARS-CoV-2 screening testing in schools for children with intellectual and developmental disabilities. J Neurodev Disord. 2021;13(1):31. PMCID:PMC8407928  PMID:34465306 
  26. Management and Microbiology of Perforated Appendicitis in Pediatric Patients: A 5-Year Retrospective Study. Infect Dis Ther. 2021. PMID:34287780 
  27. SARS-CoV-2 Screening Testing in Schools for Children with Intellectual and Developmental Disabilities. Res Sq. 2021. PMCID:PMC8312901  PMID:34312616 
  28. Pediatric antimicrobial stewardship practices at discharge: A national survey. Infect Control Hosp Epidemiol. 2021;1-3. PMID:34269167 
  29. Consensus Recommendations for Blood Culture Use in Critically Ill Children Using a Modified Delphi Approach. Pediatr Crit Care Med. 2021. PMID:33899804 
  30. Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(12):449-455. PMCID:PMC7993558  PMID:33764961 
  31. A cluster randomized stepped-wedge trial to de-implement unnecessary post-operative antibiotics in children: the optimizing perioperative antibiotic in children (OPerAtiC) trial. Implement Sci. 2021;16(1):29. PMCID:PMC7980649  PMID:33741048 
  32. Comparative in vitro effectiveness of ceftolozane/tazobactam against pediatric gram-negative drug-resistant isolates. J Chemother. 2021;1-6. PMID:33645447 
  33. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2021;10(1):34-48. PMCID:PMC7543452  PMID:32918548 
  34. Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals. J Pediatric Infect Dis Soc. 2021. PMID:33528009 
  35. Practical School Algorithms for Symptomatic or SARS-CoV-2-Exposed Students Are Essential for Returning Children to In-Person Learning. J Pediatr. 2021;229:275-277. PMCID:PMC7516575  PMID:32980377 
  36. Utilization of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative electronic mailing list (listserv) by healthcare professionals. Infect Control Hosp Epidemiol. 2020;1-3. PMID:33353577 
  37. Experiences from the Missouri Antimicrobial Stewardship Collaborative: A mixed methods study. Infect Control Hosp Epidemiol. 2020;41(12):1455-1457. PMID:32746951 
  38. Association of Intrapartum Risk Factors and Infant Clinical Indicators with Culture Confirmed Early Onset Neonatal Sepsis in a Secondary Care Rural Hospital in India. J Trop Pediatr. 2020. PMID:32853356 
  39. The current state of antifungal stewardship among pediatric antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2020;1-6. PMID:32662383 
  40. A qualitative study examining pediatric clinicians' perceptions of delayed vaccine schedules. Vaccine. 2020;38(30):4740-4746. PMCID:PMC7282958  PMID:32418792 
  41. Reductions in Parent Interest in Receiving Antibiotics Following a 90-Second Video Intervention in Outpatient Pediatric Clinics. J Pediatr. 2020. PMID:32553835 
  42. Children in the Eye of the Pandemic Storm-Lessons From New York City. JAMA Pediatr. 2020;e202438. PMID:32492094 
  43. Understanding antibiotic prophylaxis prescribing in pediatric surgical specialties. Infect Control Hosp Epidemiol. 2020;41(6):666-671. PMID:32252848 
  44. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc. 2020. PMCID:PMC7188128  PMID:32318706 
  45. Effect of Combined Clinical Practice Guideline and Electronic Order Set Implementation on Febrile Infant Evaluation and Management. Pediatr Emerg Care. 2020. PMID:32221058 
  46. Inappropriate antibiotic surgical prophylaxis in pediatric patients: A national point-prevalence study. Infect Control Hosp Epidemiol. 2020;1-3. PMID:32127068 
  47. Appropriateness of Antibiotic Prescribing in U.S. Children's Hospitals: A National Point Prevalence Survey. Clin Infect Dis. 2020. PMID:31942952 
  48. Improving Antibiotic Use Through Quality Improvement Methods: Quality Improvement for Antibiotic Use. Jt Comm J Qual Patient Saf. 2019;45(12):787-788. PMID:31783950 
  49. Skin and Soft Tissue Infection Treatment and Prevention Practices by Pediatric Infectious Diseases Providers. J Pediatric Infect Dis Soc. 2019. PMID:31773168 
  50. Practices, Perceptions, and Attitudes in the Evaluation of Critically Ill Children for Bacteremia: A National Survey. Pediatr Crit Care Med. 2019. PMID:31702704 
  51. Application of an antibiotic spectrum index in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2019;40(10):1181-1183. PMID:31352907 
  52. Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients. Infect Control Hosp Epidemiol. 2019;40(9):968-973. PMID:31311616 
  53. Use of Antimicrobial Agents in Hospitalized Children for Noninfectious Indications. J Pediatric Infect Dis Soc. 2019. PMID:32677678 
  54. World Health Organization Treatment Recommendations for Nonsevere Fast-Breathing Pneumonia Need to Be Updated. JAMA Pediatr. 2019;173(6):607-608. PMID:30985899 
  55. Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients. Infect Dis Ther. 2019;8(2):301-306. PMCID:PMC6522555  PMID:30989592 
  56. Determinants of Initial Antibiotic Duration in Very Low Birth Weight Neonates. Infect Dis Ther. 2019;8(2):209-217. doi:10.1007/s40121-019-0241-6  PMCID:PMC6522625  PMID:30825133 
  57. The Infectious Diseases Society of America's 10 × '20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × '20 a Possibility? Clin Infect Dis. 2019. PMID:30715222 
  58. Can a Septic Hip Decision Rule Aid in the Evaluation of Suspected Pediatric Musculoskeletal Infections? J Emerg Med. 2019. PMID:30679068 
  59. Development of an antimicrobial stewardship program in an integrated healthcare system. Am J Health Syst Pharm. 2019;76(1):34-43. PMID:31603982 
  60. Route of administration for antibiotics with high oral bioavailability. Infect Control Hosp Epidemiol. 2018;1-2. PMID:30587255 
  61. Variability of surgical prophylaxis in penicillin-allergic children. Infect Control Hosp Epidemiol. 2018;39(12):1480-1483. PMID:30526715 
  62. Getting Over Our Inpatient Oral Antibiotic Aversion. Pediatrics. 2018;142(6). PMID:30510032 
  63. Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016. Infect Control Hosp Epidemiol. 2018;1-4. PMID:30370879 
  64. Measuring shared decision-making in the pediatric outpatient setting: Psychometric performance of the SDM-Q-9 and CollaboRATE among English and Spanish speaking parents in the US Midwest. Patient Educ Couns. 2018. PMID:30448047 
  65. From paper to practice: Strategies for improving antibiotic stewardship in the pediatric ambulatory setting. Curr Probl Pediatr Adolesc Health Care. 2018. PMID:30322711 
  66. Improving Guideline-Based Streptococcal Pharyngitis Testing: A Quality Improvement Initiative. Pediatrics. 2018;142(1). PMID:29925574 
  67. Development and implementation of a mobile device-based pediatric electronic decision support tool as part of a national practice standardization project. J Am Med Inform Assoc. 2018. PMID:29889255 
  68. Variability in Antibiotic Use Across PICUs. Pediatr Crit Care Med. 2018;19(6):519-527. PMID:29533352 
  69. Protocol for a randomised trial of higher versus lower intensity patient-provider communication interventions to reduce antibiotic misuse in two paediatric ambulatory clinics in the USA. BMJ Open. 2018;8(5):e020981. PMCID:PMC5942422  PMID:29743330 
  70. Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. Clin Infect Dis. 2018. PMID:29590355 
  71. Zika Virus Infection in Children. Infect Dis Clin North Am. 2018;32(1):215-224. PMID:29406975 
  72. Old and New Infections of Childhood. Infect Dis Clin North Am. 2018;32(1):xiii-xiv. PMID:29406985 
  73. Infections in Children. Infect Dis Clin North Am. 2018;32(1):i. PMID:29406980 
  74. Antimicrobial Stewardship in Neonates: Challenges and Opportunities. Neonatal Netw. 2018;37(2):116-123. PMID:29615159 
  75. Understanding inpatient antimicrobial stewardship metrics. Am J Health Syst Pharm. 2018;75(4):230-238. PMID:29436469 
  76. Characteristics of Pediatric Antimicrobial Stewardship Programs: Current Status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative. Antibiotics (Basel). 2018;7(1). PMID:29370071 
  77. Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next. J Pediatric Infect Dis Soc. 2017. PMID:29267871 
  78. Trends in Intravenous Antibiotic Duration for Urinary Tract Infections in Young Infants. Pediatrics. 2017;140(6). PMID:29097611 
  79. Cost and Potential Avoidability of Antibiotic-Associated Adverse Drug Reactions in Children. J Pediatric Infect Dis Soc. 2017. PMID:29165624 
  80. Accuracy of Administrative Data for Antimicrobial Administration in Hospitalized Children. J Pediatric Infect Dis Soc. 2017. PMID:28992185 
  81. Development and Application of an Antibiotic Spectrum Index for Benchmarking Antibiotic Selection Patterns Across Hospitals. Infect Control Hosp Epidemiol. 2017;38(8):993-997. PMID:28560946 
  82. White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs. J Infect Dis. 2017;216(2):228-236. PMID:28475768 
  83. Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection. Antimicrob Agents Chemother. 2017;61(5). PMID:28289030 
  84. Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): A Quality Improvement Collaborative. J Pediatric Infect Dis Soc. 2017. PMID:28379408 
  85. Current State of Antimicrobial Stewardship in Children's Hospital Emergency Departments Infect Control Hosp Epidemiol. 2017;38(4):469-475. PMID:28173888 
  86. Experience With a Care Process Model in the Evaluation of Pediatric Musculoskeletal Infections in a Pediatric Emergency Department. Pediatr Emerg Care. 2017. PMID:28328692 
  87. Variability in Antifungal and Antiviral Use in Hospitalized Children. Infect Control Hosp Epidemiol. 2017;1-4. PMID:28294077 
  88. Extracorporeal Membrane Oxygenation-Associated Bloodstream Infections In Children. Pediatr Infect Dis J. 2017;36(3):346-347. PMID:27902647 
  89. Clinical Impact of an Antibiotic Stewardship Program at a Children's Hospital. Infect Dis Ther. 2017;6(1):103-113. PMCID:PMC5336414  PMID:27913975 
  90. Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application. Infect Dis Ther. 2017;6(1):57-67. PMCID:PMC5336419  PMID:28039666 
  91. Of the Phrensy: an update on the epidemiology and pathogenesis of bacterial meningitis in the pediatric population. F1000Res. 2017;6. PMCID:PMC5288681  PMID:28184287 
  92. Integrating a Rapid Diagnostic Test and Antimicrobial Stewardship: Optimizing Discharge Antibiotics in Skin and Soft Tissue Infections. Pediatr Infect Dis J. 2016. PMID:27649364 
  93. Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin. J Pediatric Infect Dis Soc. 2016. PMID:27609072 
  94. Impact of an Educational Intervention to Improve Antibiotic Prescribing for Nurse Practitioners in a Pediatric Urgent Care Center J Pediatr Health Care. 2016. doi:10.1016/j.pedhc.2016.07.005  PMID:27567148 
  95. Failure to Thrive Hospitalizations and Risk Factors for Readmission to Children's Hospitals. Hosp Pediatr. 2016;6(8):468-75. PMID:27439432 
  96. Costs of Antimicrobial Stewardship Programs at US Children's Hospitals. Infect Control Hosp Epidemiol. 2016;37(7):852-4. PMID:27020133 
  97. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients. Antimicrob Agents Chemother. 2016;60(7):4237-43. PMCID:PMC4914666  PMID:27139486 
  98. Extended- Versus Narrower-Spectrum Antibiotics for Appendicitis. Pediatrics. 2016;138(1). PMID:27354453 
  99. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative. Clin J Am Soc Nephrol. 2016. PMID:27340282 
  100. Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. Kidney Int. 2016;89(6):1346-54. PMID:27165827 
  101. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77. PMID:27080992 
  102. Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):1197-202. PMID:27118828 
  103. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016;315(17):1864-73. PMID:27139059 
  104. Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infect Dis Ther. 2016. doi:10.1007/s40121-016-0105-2  PMID:26972929 
  105. Reductions in neonatal listeriosis: "Collateral benefit" of Group B streptococcal prophylaxis? J Infect. 2016;72(3):317-23. doi:10.1016/j.jinf.2015.12.015  PMID:26772166 
  106. Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees. J Pediatric Infect Dis Soc. 2016. doi:10.1093/jpids/piv106  PMID:26803327 
  107. Pediatric Antimicrobial Discharge Stewardship: An Unmet Need. JAMA Pediatr. 2016;1-2. doi:10.1001/jamapediatrics.2015.3369  PMID:26752682 
  108. Encouraging Antibiotic Development and Endorsing Conservation: Tandem Approaches to Our Declining Antibiotic Reserves. Infect Control Hosp Epidemiol. 2016;1-2. doi:10.1017/ice.2015.329  PMID:26732605 
  109. Antimicrobial Stewardship Barriers and Goals in Pediatric Oncology and Bone Marrow Transplantation: A Survey of Antimicrobial Stewardship Practitioners. Infect Control Hosp Epidemiol. 2015;1-5. doi:10.1017/ice.2015.295  PMID:26639441 
  110. Linezolid-Resistant Staphylococcus aureus in Children With Cystic Fibrosis. J Pediatric Infect Dis Soc. 2015;4(4):e163-5. doi:10.1093/jpids/piv071  PMID:26501474 
  111. Boiling Over: The Antimicrobial Stewardship Stew May Finally Be Ready. J Pediatric Infect Dis Soc. 2015;4(4):394-6. doi:10.1093/jpids/piv063  PMID:26501469 
  112. Identifying Antimicrobial Stewardship Targets for Pediatric Surgical Patients. J Pediatric Infect Dis Soc. 2015;4(4):e100-8. doi:10.1093/jpids/piv022  PMID:26407258 
  113. Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children. Thromb Res. 2015. doi:10.1016/j.thromres.2015.11.029  PMID:26709039 
  114. Management of the 2014 Enterovirus 68 Outbreak at a Pediatric Tertiary Care Center. Clin Ther. 2015;37(11):2411-8. doi:10.1016/j.clinthera.2015.06.015  PMID:26602757 
  115. Surgical Site Infection Reduction by the Solutions for Patient Safety Hospital Engagement Network. Pediatrics. 2015;136(5):e1353-60. doi:10.1542/peds.2015-0580  PMID:26438709 
  116. Cost of antimicrobial therapy across US children's hospitals. Infect Control Hosp Epidemiol. 2015;36(10):1242-4. doi:10.1017/ice.2015.159  PMID:26166408 
  117. Clinical Impact of an Antimicrobial Stewardship Program on Pediatric Hospitalist Practice, a 5-Year Retrospective Analysis. Hosp Pediatr. 2015;5(10):520-7. doi:10.1542/hpeds.2014-0250  PMID:26427920 
  118. New Horizons for Pediatric Antibiotic Stewardship. Infect Dis Clin North Am. 2015;29(3):503-11. doi:10.1016/j.idc.2015.05.003  PMCID:PMC4589217  PMID:26154663 
  119. Antibiotic utilization based on primary treatment of pediatric empyema. J Surg Res. 2015;196(2):320-4. doi:10.1016/j.jss.2015.02.053  PMID:25824668 
  120. Database Research for Pediatric Infectious Diseases. J Pediatric Infect Dis Soc. 2015;4(2):143-50. doi:10.1093/jpids/piv007  PMID:26407414 
  121. Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation. Infect Control Hosp Epidemiol. 2015;36(6):673-80. doi:10.1017/ice.2015.45  PMCID:PMC4583769  PMID:25773192 
  122. Review of Twitter for infectious diseases clinicians: useful or a waste of time? Clin Infect Dis. 2015;60(10):1533-40. doi:10.1093/cid/civ071  PMID:25652087 
  123. Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak. Ann Am Thorac Soc. 2015;12(5):775-81. doi:10.1513/AnnalsATS.201412-592FR  PMID:25714788 
  124. Infection prevention and control practices in children's hospitals. Infect Control Hosp Epidemiol. 2015;36(5):597-600. doi:10.1017/ice.2015.23  PMID:25666492 
  125. An Enterovirus D68 Outbreak Highlights the Value of Pediatric Infectious Disease Specialists. J Pediatric Infect Dis Soc. 2015;4(1):87-8. doi:10.1093/jpids/piu117  PMID:26407368 
  126. Antimicrobial stewardship programs in freestanding children's hospitals. Pediatrics. 2015;135(1):33-9. doi:10.1542/peds.2014-2579  PMID:25489018 
  127. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis. 2014;210(8):1270-4. doi:10.1093/infdis/jiu245  PMCID:PMC4271072  PMID:24795475 
  128. Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol. 2014;29(9):1477-84. doi:10.1007/s00467-014-2891-7  PMID:25055994 
  129. Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States. Infect Control Hosp Epidemiol. 2014;35(3):265-71. doi:10.1086/675277  PMID:24521592 
  130. Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children. Clin Infect Dis. 2014;58(6):834-8. doi:10.1093/cid/ciu013  PMID:24399088 
  131. Linezolid use in hospitalized children. Pediatr Infect Dis J. 2014;33(1):e14-8. doi:10.1097/INF.0000000000000011  PMID:24352192 
  132. Antibiotic Management of Animal Bites in Children During the Methicillin-Resistant Staphylococcus aureus Era. J Pediatric Infect Dis Soc. 2013;2(4):379-81. doi:10.1093/jpids/pis096  PMID:26619500 
  133. Diagnosis and acute management of patients with concussion at children's hospitals. Arch Dis Child. 2013;98(12):934-8. doi:10.1136/archdischild-2012-303588  PMID:23852997 
  134. Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol. 2013;34(12):1252-8. doi:10.1086/673982  PMID:24225609 
  135. Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol. 2013;34(12):1244-51. doi:10.1086/673974  PMID:24225608 
  136. Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J. 2013;32(12):e456-65. doi:10.1097/INF.0b013e31829f0460  PMID:23958812 
  137. Incidence, classification, and risk stratification for Candida central line-associated bloodstream infections in pediatric patients at a tertiary care children's hospital, 2000-2010. Infect Control Hosp Epidemiol. 2013;34(12):1266-71. doi:10.1086/673988  PMID:24225611 
  138. Antimicrobial stewardship in pediatrics: how every pediatrician can be a steward. JAMA Pediatr. 2013;167(9):859-66. doi:10.1001/jamapediatrics.2013.2241  PMID:23857121 
  139. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013;32(6):e242-53. doi:10.1097/INF.0b013e318286c612  PMID:23838740 
  140. Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention. Int J Pediatr Otorhinolaryngol. 2013;77(5):817-20. doi:10.1016/j.ijporl.2013.02.018  PMID:23531371 
  141. Use of Administrative Data for the Identificationof Laboratory-Confirmed Influenza Infection: The Validity ofInfluenza-Specific ICD-9 Codes. J Pediatric Infect Dis Soc. 2013;2(1):63-6. doi:10.1093/jpids/pis052  PMID:26619444 
  142. The use of intravenous colistin among children in the United States: results from a multicenter, case series. Pediatr Infect Dis J. 2013;32(1):17-22. doi:10.1097/INF.0b013e3182703790  PMCID:PMC4427054  PMID:22935871 
  143. Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study. J Pediatric Infect Dis Soc. 2012;1(4):306-13. doi:10.1093/jpids/pis053  PMCID:PMC3656543  PMID:23687581 
  144. Influence of hospital guidelines on management of children hospitalized with pneumonia. Pediatrics. 2012;130(5):e823-30. doi:10.1542/peds.2012-1285  PMID:23090342 
  145. Impact of a Prospective-Audit-With-Feedback Antimicrobial Stewardship Program at a Children's Hospital. J Pediatric Infect Dis Soc. 2012;1(3):179-86. doi:10.1093/jpids/pis054  PMID:26619405 
  146. Clinicians' Attitudes Towards an Antimicrobial Stewardship Program at a Children's Hospital. J Pediatric Infect Dis Soc. 2012;1(3):190-7. doi:10.1093/jpids/pis045  PMID:26619407 
  147. Antimicrobial stewardship in pediatric care: strategies and future directions. Pharmacotherapy. 2012;32(8):735-43. doi:10.1002/j.1875-9114.2012.01155.x  PMID:23307521 
  148. Unmet medical need in infectious diseases. Clin Infect Dis. 2012;54(11):1677-8. doi:10.1093/cid/cis275  PMCID:PMC3404719  PMID:22474176 
  149. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int. 2012;32 Suppl 2:S32-86. doi:10.3747/pdi.2011.00091  PMCID:PMC3524923  PMID:22851742 
  150. Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Pediatrics. 2012;129(3):e597-604. doi:10.1542/peds.2011-1533  PMID:22351891 
  151. The role of intention-to-treat analyses in randomized trials. Infect Control Hosp Epidemiol. 2012;33(2):207-8; author reply 208-10. doi:10.1086/663963  PMID:22227995 
  152. Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy. Otolaryngol Head Neck Surg. 2011;145(6):1025-9. doi:10.1177/0194599811419098  PMID:21846926 
  153. Staphylococcal infections in the era of MRSA. Pediatr Rev. 2011;32(12):522-32. doi:10.1542/pir.32-12-522  PMID:22135422 
  154. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J. 2011;30(10):895-7. doi:10.1097/INF.0b013e3182214e28  PMID:21587093 
  155. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J. 2011;30(9):736-9. doi:10.1097/INF.0b013e3182191c58  PMID:21772230 
  156. Influenza coinfection and outcomes in children with complicated pneumonia. Arch Pediatr Adolesc Med. 2011;165(6):506-12. doi:10.1001/archpediatrics.2010.295  PMID:21300649 
  157. Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood. J Hosp Med. 2011;6(5):256-63. doi:10.1002/jhm.872  PMCID:PMC3112472  PMID:21374798 
  158. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool. Pediatr Infect Dis J. 2011;30(3):e38-40. doi:10.1097/INF.0b013e3182027c22  PMID:21079527 
  159. Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant. Paediatr Drugs. 2011;13(1):19-31. doi:10.2165/11536950-000000000-00000  PMID:21162598 
  160. Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PLoS One. 2011;6(5):e20325. doi:10.1371/journal.pone.0020325  PMCID:PMC3105054  PMID:21655259 
  161. Variability in antibiotic use at children's hospitals. Pediatrics. 2010;126(6):1067-73. doi:10.1542/peds.2010-1275  PMCID:PMC4677056  PMID:21078728 
  162. Antibiotics provide no additional short-term benefit to surgical management of paediatric skin abscesses. Evid Based Med. 2010;15(5):138-9. doi:10.1136/ebm1101  PMID:20643760 
  163. Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J. 2010;29(9):862-3. doi:10.1097/INF.0b013e3181ef2507  PMID:20720473 
  164. A complete course of intravenous antibiotics vs a combination of intravenous and oral antibiotics for perforated appendicitis in children: a prospective, randomized trial. J Pediatr Surg. 2010;45(6):1198-202. doi:10.1016/j.jpedsurg.2010.02.090  PMID:20620320 
  165. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics. 2010;125(6):e1294-300. doi:10.1542/peds.2009-2867  PMID:20478934 
  166. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30(12):1211-7. doi:10.1086/648088  PMID:19852666 
  167. Update on terbinafine with a focus on dermatophytoses. Clin Cosmet Investig Dermatol. 2009;2:49-63. PMCID:PMC3047923  PMID:21436968 
  168. Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics. Paediatr Drugs. 2008;10(6):367-78. PMID:18998747 
  169. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150(3):306-10. doi:10.1016/j.jpeds.2006.11.054  PMID:17307552 
  170. Diagnosis of viral encephalitides: zoonotic-associated viruses. Pediatr Infect Dis J. 2006;25(8):741-2. doi:10.1097/01.inf.0000227815.41511.3b  PMID:16874176 
  171. Diagnosis of viral encephalitides: nonzoonotic-associated viruses. Pediatr Infect Dis J. 2006;25(8):739-40. doi:10.1097/01.inf.0000227818.40808.92  PMID:16874175 
  172. The child with aseptic meningitis. Pediatr Case Rev. 2003;3(4):218-21. doi:10.1097/01.PCA.0000083250.03358.9F  PMID:14520085 
  173. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis. 2003;14(2):72-82. doi:10.1053/spid.2003.127223  PMID:12881794 
  174. Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin Infect Dis. 2003;36(7):e87-95. doi:10.1086/368184  PMID:12652406 
  175. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol. 2000;120(1):209-17. PMCID:PMC1905619  PMID:10759785 
Last updated: 09/09/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130